Advanced search
Publication Cover
Current Medical Research and Opinion Volume 22, 2006 - Issue 6
Submit an article Journal homepage
182
Views
32
CrossRef citations to date
0
Altmetric
Original Article

The impact of migraine on daily activities: effect of topiramate compared with placebo

Stephen D. Silberstein Jefferson Headache Center, Philadelphia, PA, USA
,
Elizabeth Loder Spaulding Rehabilitation Hospital, Boston, MA, USA
,
Grace Forde North Shore Pain Services, Valley Stream, NY, USA
,
George Papadopoulos Johnson & Johnson Pharmaceutical Services, LLC, Raritan, NJ, USA
,
Diane Fairclough University of Colorado Health Science Center, Aurora, CO, USA
&
Steven Greenberg Ortho-McNeil Neurologics, Titusville, NJ, USA
Pages 1021-1029 | Accepted 24 Mar 2006, Published online: 21 Apr 2006

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Shu-zhi Wu & Linglong Chen. (2022) Efficacy and safety of ubrogepant for migraine: a meta-analysis of randomized controlled studies. International Journal of Neuroscience 0:0, pages 1-7.
Read now
Lorenza Chiossi, Andrea Negro, Matilde Capi, Luana Lionetto & Paolo Martelletti. (2014) Sodium channel antagonists for the treatment of migraine. Expert Opinion on Pharmacotherapy 15:12, pages 1697-1706.
Read now
Anna Ferrari, Ilaria Tiraferri, Laura Neri & Emilio Sternieri. (2011) Clinical pharmacology of topiramate in migraine prevention. Expert Opinion on Drug Metabolism & Toxicology 7:9, pages 1169-1181.
Read now
Manuela Fontebasso. (2007) Topiramate for migraine prophylaxis. Expert Opinion on Pharmacotherapy 8:16, pages 2811-2823.
Read now

Articles from other publishers (28)

Uwe Reuter, Marc Ehrlich, Astrid Gendolla, Axel Heinze, Jan Klatt, Shihua Wen, Peggy Hours-Zesiger, Jacqueline Nickisch, Christian Sieder, Christian Hentschke & Monika Maier-Peuschel. (2021) Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial. Cephalalgia 42:2, pages 108-118.
Crossref
Ting Zhou, Yongguo Tang & Hui Zhu. (2022) Effectiveness and Safety of Memantine for Headache: A Meta-analysis of Randomized Controlled Studies. Clinical Neuropharmacology Publish Ahead of Print.
Crossref
Liyan Chen & Zhiyou Cai. (2021) The efficacy of ginger for the treatment of migraine: A meta-analysis of randomized controlled studies. The American Journal of Emergency Medicine 46, pages 567-571.
Crossref
Zhili Xu, Linglong Chen, Shuang Jin, Xinguo Chen & Baohua Yang. (2021) The Efficacy of Memantine for the Treatment of Migraine: A Meta-Analysis of Randomized Controlled Studies. Clinical Neuropharmacology 44:3, pages 94-98.
Crossref
Yuan-feng Zhang, Zhi-qiang Xu, Hong-jie Zhou, Ya-zhen Liu & Xiao-jiang Jiang. (2021) The Efficacy of Vitamin D Supplementation for Migraine: A Meta-Analysis of Randomized Controlled Studies. Clinical Neuropharmacology 44:1, pages 5-8.
Crossref
Ping‐Tao Tseng, Chun‐Pai Yang, Kuan‐Pin Su, Tien‐Yu Chen, Yi‐Cheng Wu, Yu‐Kang Tu, Pao‐Yen Lin, Brendon Stubbs, Andre F. Carvalho, Yutaka J. Matsuoka, Dian‐Jeng Li, Chih‐Sung Liang, Chih‐Wei Hsu, Yen‐Wen Chen & Yow‐Ling Shiue. (2020) The association between melatonin and episodic migraine: A pilot network meta‐analysis of randomized controlled trials to compare the prophylactic effects with exogenous melatonin supplementation and pharmacotherapy. Journal of Pineal Research 69:2.
Crossref
Amy W. Voigt & Harry J. GouldIIIIII. (2016) Chronic Daily Headache: Mechanisms and Principles of Management. Current Pain and Headache Reports 20:2.
Crossref
Alberto Raggi, Silvia Schiavolin, Matilde Leonardi, Ambra Mara Giovannetti, Gennaro Bussone, Marcella Curone, Paola Di Fiore, Licia Grazzi, Susanna Usai & Domenico D'Amico. (2015) Chronic migraine with medication overuse: Association between disability and quality of life measures, and impact of disease on patients' lives. Journal of the Neurological Sciences 348:1-2, pages 60-66.
Crossref
Mattias Linde, Wim M Mulleners, Edward P Chronicle & Douglas C McCrory. (2013) Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews.
Crossref
Peer Tfelt-Hansen, Julio Pascual, Nabih Ramadan, Carl Dahlöf, Domenico D'Amico, Hans-Christopher Diener, Jakob Møller Hansen, Michel Lanteri-Minet, Elisabeth Loder, Douglas McCrory, Sandra Plancade & Todd Schwedt. (2012) Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators. Cephalalgia 32:1, pages 6-38.
Crossref
Alberto Raggi, Matilde Leonardi, Gennaro Bussone & Domenico D?Amico. (2010) Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life. Neurological Sciences 32:3, pages 387-392.
Crossref
RC Kessler, V Shahly, PE Stang & MC Lane. (2010) The associations of migraines and other headaches with work performance: Results from the National Comorbidity Survey Replication (NCS-R). Cephalalgia 30:6, pages 722-734.
Crossref
Jan Lewis Brandes. (2009) Migraine and Functional Impairment. CNS Drugs 23:12, pages 1039-1045.
Crossref
Stephen Silberstein, Richard Lipton, David Dodick, Fred Freitag, Ninan Mathew, Jan Brandes, Marcelo Bigal, Steven Ascher, Jacqueline Morein, Pamela Wright, Steven Greenberg & Joseph Hulihan. (2009) Topiramate Treatment of Chronic Migraine: A Randomized, Placebo-Controlled Trial of Quality of Life and Other Efficacy Measures. Headache: The Journal of Head and Face Pain 49:8, pages 1153-1162.
Crossref
Dawn C. Buse, Marcia F.T. Rupnow & Richard B. Lipton. (2009) Assessing and Managing All Aspects of Migraine: Migraine Attacks, Migraine-Related Functional Impairment, Common Comorbidities, and Quality of Life. Mayo Clinic Proceedings 84:5, pages 422-435.
Crossref
Richard P. Shank & Bruce E. Maryanoff. (2008) Molecular Pharmacodynamics, Clinical Therapeutics, and Pharmacokinetics of Topiramate. CNS Neuroscience & Therapeutics 14:2, pages 120-142.
Crossref
Robert Kaniecki. (2008) Neuromodulators for Migraine Prevention. Headache: The Journal of Head and Face Pain 48:4, pages 586-600.
Crossref
Jan Lewis Brandes. (2008) The Migraine Cycle: Patient Burden of Migraine During and Between Migraine Attacks. Headache: The Journal of Head and Face Pain 48:3, pages 430-441.
Crossref
Wendy L. Wright. (2008) Assessing Functional Impairment During and Between Migraine Attacks. The Journal for Nurse Practitioners 4:3, pages 201-207.
Crossref
Richard L Doty, Muhammad Shah & Steven M Bromley. (2008) Drug-Induced Taste Disorders. Drug Safety 31:3, pages 199-215.
Crossref
Carl Dahlöf, Elizabeth Loder, Merle Diamond, Marcia Rupnow, George Papadopoulos & Lian Mao. (2007) The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health and Quality of Life Outcomes 5:1.
Crossref
David W. Dodick, Stephen Silberstein, Joel Saper, Fred G. Freitag, Roger K. Cady, Alan M. Rapoport, Ninan T. Mathew, Joseph Hulihan, Concetta Crivera, Marcia F.T. Rupnow, Lian Mao, Gary Finlayson & Steven J. Greenberg. (2007) The Impact of Topiramate on Health-Related Quality of Life Indicators in Chronic Migraine. Headache: The Journal of Head and Face Pain 47:10, pages 1398-1408.
Crossref
Anthony L. Feliu, Marcia F. T. Rupnow, Angela Blount, Stephen J. Boccuzzi & James Vermilyea. (2007) Resource use associated with topiramate in migraine prophylaxis. American Journal of Health-System Pharmacy 64:14, pages 1483-1491.
Crossref
Stephen D. Silberstein, Anthony L. Feliu, Marcia F.T. Rupnow, Angela C. Blount & Stephen J. Boccuzzi. (2007) Topiramate in Migraine Prophylaxis: Long-Term Impact on Resource Utilization and Cost. Headache: The Journal of Head and Face Pain 47:4, pages 500-510.
Crossref
Mi-Sun YumKeun Wook BaeSu Jeong YouTae Sung Ko. (2007) Topiramate can reduce the number of episodic attacks in cyclic vomiting syndrome : a case report. Korean Journal of Pediatrics 50:4, pages 386.
Crossref
Josef Finsterer, Daniela Földy & Elisabeth Fertl. (2006) Topiramate Resolves Headache from Pseudotumor Cerebri. Journal of Pain and Symptom Management 32:5, pages 401-402.
Crossref
. (2013) Topiramate improves daily activities for patients with migraine. PharmacoEconomics & Outcomes News 509:1, pages 8-8.
Crossref
Uwe Reuter, Marc Ehrlich, Astrid Gendolla, Axel Heinze, Jan Klatt, Shihua Wen, Peggy Hours-Zesiger, Jaqueline Nickisch, Christian Hentschke, Christian Sieder & Monika Maier-Peuschel. (2021) Erenumab Versus Topiramate for the Prevention of Migraine – A Randomised, Double-Blind, Active-Controlled Phase 4 Trial. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.